- Home
- IIIN vs KALV Comparison
IIIN vs KALV Comparison
Compare IIIN & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIIN
- KALV
- Stock Information
- Founded
- IIIN 1953
- KALV N/A
- Country
- IIIN United States
- KALV United States
- Employees
- IIIN N/A
- KALV N/A
- Industry
- IIIN Steel/Iron Ore
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- IIIN Industrials
- KALV Health Care
- Exchange
- IIIN Nasdaq
- KALV Nasdaq
- Market Cap
- IIIN 712.0M
- KALV 637.9M
- IPO Year
- IIIN N/A
- KALV N/A
- Fundamental
- Price
- IIIN $38.38
- KALV $13.35
- Analyst Decision
- IIIN
- KALV Strong Buy
- Analyst Count
- IIIN 0
- KALV 9
- Target Price
- IIIN N/A
- KALV $26.29
- AVG Volume (30 Days)
- IIIN 102.5K
- KALV 614.3K
- Earning Date
- IIIN 10-16-2025
- KALV 09-09-2025
- Dividend Yield
- IIIN 2.93%
- KALV N/A
- EPS Growth
- IIIN 53.01
- KALV N/A
- EPS
- IIIN 1.59
- KALV N/A
- Revenue
- IIIN $604,566,000.00
- KALV N/A
- Revenue This Year
- IIIN $24.62
- KALV N/A
- Revenue Next Year
- IIIN $7.01
- KALV $221.95
- P/E Ratio
- IIIN $24.05
- KALV N/A
- Revenue Growth
- IIIN 9.44
- KALV N/A
- 52 Week Low
- IIIN $22.49
- KALV $7.30
- 52 Week High
- IIIN $41.64
- KALV $16.32
- Technical
- Relative Strength Index (RSI)
- IIIN 58.39
- KALV 53.99
- Support Level
- IIIN $36.46
- KALV $12.90
- Resistance Level
- IIIN $39.20
- KALV $13.65
- Average True Range (ATR)
- IIIN 0.85
- KALV 0.54
- MACD
- IIIN 0.20
- KALV 0.11
- Stochastic Oscillator
- IIIN 73.78
- KALV 80.90
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.